For: | Xu MY, Xu XH, Chen GZ, Deng XL, Li J, Yu XJ, Chen MZ. Production of a human single-chain variable fragment antibody against esophageal carcinoma. World J Gastroenterol 2004; 10(18): 2619-2623 [PMID: 15309706 DOI: 10.3748/wjg.v10.i18.2619] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i18/2619.htm |
Number | Citing Articles |
1 |
Bing Du, Min Qian, Zhongliang Zhou, Peng Wang, Lei Wang, Xiaoping Zhang, Miao Wu, Ping Zhang, Bing Mei. In vitro panning of a targeting peptide to hepatocarcinoma from a phage display peptide library. Biochemical and Biophysical Research Communications 2006; 342(3): 956 doi: 10.1016/j.bbrc.2006.02.050
|
2 |
Elena Lastraioli, Tiziano Lottini, Jessica Iorio, Giancarlo Freschi, Marilena Fazi, Claudia Duranti, Laura Carraresi, Luca Messerini, Antonio Taddei, Maria Novella Ringressi, Marianna Salemme, Vincenzo Villanacci, Carla Vindigni, Anna Tomezzoli, Roberta La Mendola, Maria Bencivenga, Bruno Compagnoni, Mariella Chiudinelli, Luca Saragoni, Ilaria Manzi, Giovanni De Manzoni, Paolo Bechi, Luca Boni, Annarosa Arcangeli. hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance. Oncotarget 2016; 7(37): 59535 doi: 10.18632/oncotarget.11149
|
3 |
Krista M McCutcheon, Julia Gray, Natalie Y Chen, Keyi Liu, Minha Park, Stote Ellsworth, Ralph A Tripp, S Mark Tompkins, Scott K Johnson, Shelly Samet, Lenore Pereira, Lawrence M Kauvar. Multiplexed screening of natural humoral immunity identifies antibodies at fine specificity for complex and dynamic viral targets. mAbs 2014; 6(2): 460 doi: 10.4161/mabs.27760
|
4 |
Mohamed Alfaleh, Martina Jones, Christopher Howard, Stephen Mahler. Strategies for Selecting Membrane Protein-Specific Antibodies using Phage Display with Cell-Based Panning. Antibodies 2017; 6(3): 10 doi: 10.3390/antib6030010
|
5 |
Ayda Hassanzadeh Eskafi, Akbar Oghalaei, Fereidoun Mahboudi, Hajarsadat Ghaderi, Mahdi Behdani, Alireza Shoari, Fatemeh Kazemi-Lomedasht. Investigation of the therapeutic potential of recombinant bispecific bivalent anti-PD-L1/VEGF nanobody in inhibition of angiogenesis. Immunopharmacology and Immunotoxicology 2023; 45(2): 197 doi: 10.1080/08923973.2022.2131571
|
6 |
David Sánchez-Martín, Morten Dræby Sørensen, Simon Lykkemark, Laura Sanz, Peter Kristensen, Erkki Ruoslahti, Luis Álvarez-Vallina. Selection strategies for anticancer antibody discovery: searching off the beaten path. Trends in Biotechnology 2015; 33(5): 292 doi: 10.1016/j.tibtech.2015.02.008
|
7 |
Mohamed A. Alfaleh, Hashem O. Alsaab, Ahmad Bakur Mahmoud, Almohanad A. Alkayyal, Martina L. Jones, Stephen M. Mahler, Anwar M. Hashem. Phage Display Derived Monoclonal Antibodies: From Bench to Bedside. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01986
|
8 |
Emiliano Pavoni, Paola Vaccaro, Anna Maria Anastasi, Olga Minenkova. Optimized selection of anti-tumor recombinant antibodies from phage libraries on intact cells. Molecular Immunology 2014; 57(2): 317 doi: 10.1016/j.molimm.2013.10.009
|
9 |
Patrick S Lown, Jessy J Cai, Seth C Ritter, Jacob J Otolski, Ryan Wong, Benjamin J Hackel. Extended yeast surface display linkers enhance the enrichment of ligands in direct mammalian cell selections. Protein Engineering, Design and Selection 2021; 34 doi: 10.1093/protein/gzab004
|
10 |
Seyedeh Zahra Bahojb Mahdavi, Fatemeh Oroojalian, Shirin Eyvazi, Maryam Hejazi, Behzad Baradaran, Nasser Pouladi, Mohammad Reza Tohidkia, Ahad Mokhtarzadeh, Serge Muyldermans. An overview on display systems (phage, bacterial, and yeast display) for production of anticancer antibodies; advantages and disadvantages. International Journal of Biological Macromolecules 2022; 208: 421 doi: 10.1016/j.ijbiomac.2022.03.113
|
11 |
Nicola Clementi, Nicasio Mancini, Laura Solforosi, Matteo Castelli, Massimo Clementi, Roberto Burioni. Phage Display-based Strategies for Cloning and Optimization of Monoclonal Antibodies Directed against Human Pathogens. International Journal of Molecular Sciences 2012; 13(7): 8273 doi: 10.3390/ijms13078273
|
12 |
Bing Du, Honghui Han, Ziqiang Wang, Lisha Kuang, Lei Wang, Liping Yu, Miao Wu, Zhongliang Zhou, Min Qian. Targeted Drug Delivery to Hepatocarcinoma In vivo by Phage-Displayed Specific Binding Peptide. Molecular Cancer Research 2010; 8(2): 135 doi: 10.1158/1541-7786.MCR-09-0339
|
13 |
Patrick S. Lown, Benjamin J. Hackel. Magnetic Bead-Immobilized Mammalian Cells Are Effective Targets to Enrich Ligand-Displaying Yeast. ACS Combinatorial Science 2020; 22(5): 274 doi: 10.1021/acscombsci.0c00036
|
14 |
Yasaman Asaadi, Fatemeh Fazlollahi Jouneghani, Sara Janani, Fatemeh Rahbarizadeh. A comprehensive comparison between camelid nanobodies and single chain variable fragments. Biomarker Research 2021; 9(1) doi: 10.1186/s40364-021-00332-6
|
15 |
Emiliano Pavoni, Giorgia Monteriù, Daniela Santapaola, Fiorella Petronzelli, Anna Maria Anastasi, Angela Pelliccia, Valeria D'Alessio, Rita De Santis, Olga Minenkova. Tumor-infiltrating B lymphocytes as an efficient source of highly specific immunoglobulins recognizing tumor cells. BMC Biotechnology 2007; 7(1) doi: 10.1186/1472-6750-7-70
|
16 |
Stephanie C. Pero, Yu-Jing Sun, Girja S. Shukla, Chelsea L. Carman, Christopher C. Krag, Cory Teuscher, Dimitry N. Krementsov, David N. Krag. Vaccine draining lymph nodes are a source of antigen-specific B cells. Vaccine 2017; 35(9): 1259 doi: 10.1016/j.vaccine.2017.01.036
|
17 |
Girja S. Shukla, Walter C. Olson, Stephanie C. Pero, Yu-jing Sun, Chelsea L. Carman, Craig L. Slingluff, David N. Krag. Vaccine-draining lymph nodes of cancer patients for generating anti-cancer antibodies. Journal of Translational Medicine 2017; 15(1) doi: 10.1186/s12967-017-1283-8
|
18 |
Sepideh Nikfarjam, Mohammad Reza Tohidkia, Tayebeh Mehdipour, Ramin Soleimani, Ali Akbar Rahim Rahimi, Mohammad Nouri. Successful Application of Whole Cell Panning for Isolation of PhageAntibody Fragments Specific to Differentiated Gastric Cancer Cells. Advanced Pharmaceutical Bulletin 2019; 9(4): 624 doi: 10.15171/apb.2019.072
|